Filing Details

Accession Number:
0000899243-17-028577
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-12 21:08:43
Reporting Period:
2017-12-11
Accepted Time:
2017-12-12 21:08:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1537917 Tyme Technologies Inc. TYME Pharmaceutical Preparations (2834) 453864597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1712467 Michael Demurjian C/O Tyme Technologies, Inc.
44 Wall Street - 12Th Floor
New York NY 10005
Chief Operating Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-12-11 1,900 $3.73 26,678,536 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $3.75, inclusive. The reporting person undertakes to provide to Tyme Technologies, Inc., any security holder of Tyme Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.